Gland Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2017
Period Ending	Sep '24 Sep 6, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2019 - 2017
Market Capitalization	314,017	303,932	208,882	537,705	405,432	-	Upgrade
Market Cap Growth	71.80%	45.50%	-61.15%	32.63%	-	-	Upgrade
Enterprise Value	299,344	286,055	175,977	508,469	390,204	-	Upgrade
Last Close Price	1906.00	1826.40	1255.30	3239.23	2452.99	-	Upgrade
PE Ratio	43.48	38.95	26.47	43.99	38.94	-	Upgrade
PS Ratio	5.36	5.37	5.76	12.22	11.71	-	Upgrade
PB Ratio	3.60	3.48	2.62	7.51	6.87	-	Upgrade
P/FCF Ratio	-	50.08	146.03	192.42	107.78	-	Upgrade
P/OCF Ratio	-	30.49	57.39	68.00	67.02	-	Upgrade
EV/Sales Ratio	5.11	5.05	4.86	11.55	11.27	-	Upgrade
EV/EBITDA Ratio	22.57	21.77	17.07	33.67	29.97	-	Upgrade
EV/EBIT Ratio	32.11	28.94	19.90	36.32	32.42	-	Upgrade
EV/FCF Ratio	-	47.14	123.03	181.96	103.74	-	Upgrade
Debt / Equity Ratio	0.04	0.04	0.00	0.00	0.00	0.00	Upgrade
Debt / EBITDA Ratio	0.28	0.28	0.00	0.00	0.00	0.01	Upgrade
Debt / FCF Ratio	-	0.61	0.03	0.02	0.01	0.01	Upgrade
Asset Turnover	-	0.58	0.44	0.61	0.65	0.69	Upgrade
Inventory Turnover	-	1.40	1.16	1.79	1.56	1.43	Upgrade
Quick Ratio	-	2.61	6.58	7.80	7.31	5.50	Upgrade
Current Ratio	-	4.04	9.46	10.05	10.00	7.93	Upgrade
Return on Equity (ROE)	-	9.26%	10.33%	18.55%	20.88%	23.75%	Upgrade
Return on Assets (ROA)	-	6.36%	6.66%	12.21%	14.22%	14.14%	Upgrade
Return on Capital (ROIC)	6.83%	7.24%	7.31%	13.39%	15.73%	16.50%	Upgrade
Earnings Yield	2.30%	2.54%	3.74%	2.25%	2.46%	-	Upgrade
FCF Yield	2.00%	0.68%	0.52%	0.93%	-	Upgrade
Dividend Yield	1.05%	1.10%	-	-	-	-	Upgrade
Buyback Yield / Dilution	-0.00%	-0.03%	-0.09%	-3.95%	-2.15%	-	Upgrade
Total Shareholder Return	1.05%	1.06%	-0.09%	-3.95%	-2.15%	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.